{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T03:42:45Z","timestamp":1794368565775,"version":"4.9.0"},"reference-count":28,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T00:00:00Z","timestamp":1566432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and objectives: The use of antagonistic probiotic microorganisms and their byproducts represents a promising approach for the treatment of viral diseases. In the current work, the effect of exopolysaccharides (EPSs) produced by lactic acid bacteria from different genera on the structural and functional characteristics of cells and the development of adenoviral infection in vitro was studied. Materials and Methods: Cytotoxicity of six EPSs of lactic acid bacteria of the genera Lactobacillus, Leuconostoc and Pediococcus was determined by MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) assay. The influence of the EPSs on the infectivity of human adenovirus type 5 (HAdV-5) and on the cell cycle under a condition of adenovirus infection was studied using plaque reduction assay and flow cytometric analysis, respectively. Results: It was shown that exopolysaccharides were non-toxic to Madin-Darby bovine kidney cells (MDBK) as they reduced their viability by 3\u201317%. A change in the distribution of the cell cycle phases in the non-infected cell population treated with EPSs was observed. The analysis demonstrated an increase in the number of cells in the S phase by 47% when using EPSs 15a and a decrease in the number of cells in the G1 phase by 20\u201327% when treated with the EPSs 15a, 33a, and 19s. The use of EPSs did not led to the normalization of the life cycle of HAdV-5 infected cells to the level of non-infected cells. The EPSs showed low virucidal activity and reduced the HAdV-5 infectivity to 85%. Among the studied exopolysaccharides, anti-adenovirus activity was found for EPS 26a that is produced by Lactobacillus spp. strain. The treatment of cells with the EPS following virus adsorption completely (100%) suppressed the formation and release of HAdV-5 infectious. Conclusions: EPS 26a possessed distinct anti-HAdV-5 activity and the obtained data demonstrate the potential of using exopolysaccharides as anti-adenoviral agents.<\/jats:p>","DOI":"10.3390\/medicina55090519","type":"journal-article","created":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T10:15:07Z","timestamp":1566555307000},"page":"519","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":72,"title":["Antiviral Activity of Exopolysaccharides Produced by Lactic Acid Bacteria of the Genera Pediococcus, Leuconostoc and Lactobacillus against Human Adenovirus Type 5"],"prefix":"10.3390","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3163-2492","authenticated-orcid":false,"given":"Liubov","family":"Biliavska","sequence":"first","affiliation":[{"name":"Zabolotny Institute of Microbiology and Virology, National Academy of Sciences of Ukraine, 03143 Kyiv, Ukraine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3344-7103","authenticated-orcid":false,"given":"Yulia","family":"Pankivska","sequence":"additional","affiliation":[{"name":"Zabolotny Institute of Microbiology and Virology, National Academy of Sciences of Ukraine, 03143 Kyiv, Ukraine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Povnitsa","sequence":"additional","affiliation":[{"name":"Zabolotny Institute of Microbiology and Virology, National Academy of Sciences of Ukraine, 03143 Kyiv, Ukraine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svitlana","family":"Zagorodnya","sequence":"additional","affiliation":[{"name":"Zabolotny Institute of Microbiology and Virology, National Academy of Sciences of Ukraine, 03143 Kyiv, Ukraine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,8,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1556\/EuJMI.4.2014.1.2","article-title":"Human adenovirus: Viral pathogen with increasing importance","volume":"4","author":"Ghebremedhin","year":"2014","journal-title":"Eur. J. Microbiol. Immunol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1038\/srep01812","article-title":"Molecular evolution of human adenoviruses","volume":"3","author":"Robinson","year":"2013","journal-title":"Sci. Rep."},{"key":"ref_3","first-page":"3866","article-title":"Curious (old and new) antiviral nucleoside analogues with intriguing therapeutic potential","volume":"22","year":"2015","journal-title":"Med. Chem."},{"key":"ref_4","first-page":"19","article-title":"Experimental Study of Ingavirin\u00ae Antiviral Activity Against Human Adenovirus","volume":"55","author":"Zarubaev","year":"2010","journal-title":"Antibiotiki i khimioterapiia"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"7171","DOI":"10.1128\/AAC.03860-14","article-title":"Ganciclovir inhibits human adenovirus replication and pathogenicity in permissive immunosuppressive Syrian hamsters","volume":"58","author":"Ying","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/978-1-4615-4743-3_10","article-title":"Cidofovir. Review of current and potential clinical uses","volume":"458","author":"Safrin","year":"1999","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1128\/CMR.00102-15","article-title":"Approved Antiviral Drugs over the Past 50 Years","volume":"29","author":"Li","year":"2016","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1177\/135965350901400110","article-title":"Differential susceptibility of adenovirus clinical isolates to cidofovir and ribavirin is not related to species alone","volume":"14","author":"Morfin","year":"2009","journal-title":"Antivir. Ther."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.3390\/ph3103343","article-title":"Anti-Viral Drugs for Human Adenoviruses","volume":"3","author":"Waye","year":"2010","journal-title":"Pharmaceuticals"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0166-3542(02)00212-7","article-title":"Inhibition of adenovirus infection and adenain by green tea catechins","volume":"58","author":"Weber","year":"2003","journal-title":"Antiviral Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1006\/smvy.1993.1019","article-title":"Adenovirus inhibition of cellular protein synthesis and the specific translation of late viral mRNAs","volume":"4","author":"Zhang","year":"1993","journal-title":"Semin. Virol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1039\/C4FO00529E","article-title":"Sugarcoated: Exopolysaccharide producing lactic acid bacteria for food and human health applications","volume":"6","author":"Ryan","year":"2015","journal-title":"Food Func."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s12602-014-9162-6","article-title":"Antiviral Potential of Lactic Acid Bacteria and Their Bacteriocins","volume":"6","author":"Kassaa","year":"2014","journal-title":"Probiotics Antimicro."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"464","DOI":"10.3390\/microorganisms3030464","article-title":"Role of Bacterial Exopolysaccharides as Agents in Counteracting Immune Disorders Induced by Herpes Virus","volume":"3","author":"Gugliandolo","year":"2015","journal-title":"Microorganisms"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Green, M., and Loewenstein, P.M. (2006). Human adenoviruses: Propagation, purification, quantification, and storage. Curr. Protoc. Microbiol., 14C.1.1\u201314C.1.19.","DOI":"10.1002\/9780471729259.mc14c01s00"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3934\/microbiol.2016.3.372","article-title":"Isolation and characterization of lactic acid bacteria from Ukrainian traditional dairy products","volume":"2","author":"Garmasheva","year":"2016","journal-title":"AIMS Microbiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"76","DOI":"10.18524\/2307-4663.2017.4(40).118933","article-title":"Exopolysaccharides Production By Lactic Acid Bacteria Strains Isolated From Fernmented Products","volume":"4","author":"Garmasheva","year":"2017","journal-title":"Microbiology&Biotechnology"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and surviral: Application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"28.6.1","DOI":"10.1002\/0471142727.mb2806s111","article-title":"Assaying cell cycle status using flow cytometry","volume":"111","author":"Kim","year":"2015","journal-title":"Curr Protoc Mol Biol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0166-3542(99)00070-4","article-title":"Inhibition of herpes simplex virus type 1 and adenovirus type 5 by heterocyclic Schiff bases of aminohydroxyguanidine tosylate","volume":"44","author":"Das","year":"1999","journal-title":"Antivir. Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jviromet.2008.03.007","article-title":"Development of plaque assays for adenoviruses 40 and 41","volume":"151","author":"Cromeans","year":"2008","journal-title":"J. Virol. Methods."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1590\/1516-635X1703275-280","article-title":"In Vitro Antiviral Activities of Extracts of Plants of The Brazilian Cerrado against the Avian Metapneumovirus (aMPV)","volume":"17","author":"Kohn","year":"2015","journal-title":"Braz. J. Poultry Sci."},{"key":"ref_23","first-page":"1","article-title":"Cell Cycle Modulation by Marek\u2019s Disease Virus: The Tegument Protein VP22 Triggers S-Phase Arrest and DNA Damage in Proliferating Cells","volume":"9","author":"Bencherit","year":"2014","journal-title":"PLOS ONE"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1006\/viro.1998.9102","article-title":"Human Cells Arrest in S Phase in Response to Adenovirus 12 E1A","volume":"244","author":"Grand","year":"1998","journal-title":"Virology"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1021\/bp070198s","article-title":"Monitoring of the Adenovirus Production Process by Flow Cytometry","volume":"24","author":"Sandhu","year":"2008","journal-title":"Biotechnol Prog."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"184","DOI":"10.4172\/2329-8901.1000184","article-title":"Antiviral Effects of a Probiotic Metabolic Products against Transmissible Gastroenteritis Coronavirus","volume":"5","author":"Yang","year":"2017","journal-title":"J Prob Health."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"17360","DOI":"10.1038\/s41598-017-17487-8","article-title":"Heat-killed Lactobacillus casei confers broad protection against influenza A virus primary infection and develops heterosubtypic immunity against future secondary infection","volume":"7","author":"Jung","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1089\/bfm.2010.0001","article-title":"Inhibition of Human Immunodeficiency Virus Type 1 by Lactic Acid Bacteria from Human Breastmilk","volume":"5","author":"Maldonado","year":"2010","journal-title":"Breastfeed Med."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/55\/9\/519\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:13:13Z","timestamp":1760188393000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/55\/9\/519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,22]]},"references-count":28,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2019,9]]}},"alternative-id":["medicina55090519"],"URL":"https:\/\/doi.org\/10.3390\/medicina55090519","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,22]]}}}